Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutiform vs Seretide in COPD
NCT02195375Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Sep 2014
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Mundipharma. Started Sep 2014; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02195375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195375.